Immune Effector Cell Associated Encephalopathy (ICE) TOOL

The ICE tool is a 10‑point bedside cognitive assessment used to rapidly screen for ICANS in adults receiving immune effector cell therapies.

Orientation to year, month, city, hospital
No0Yes+4
Ability to name 3 objects
No0Yes+3
Ability to write a standard sentence
No0Yes+1
Ability to count backwards from 100 by 10
No0Yes+1

Indications d'utilisation

Used in all adults receiving CAR‑T or other immune‑effector cell therapies to screen, score, and track early neurotoxicity as part of ICANS grading. Provides a rapid bedside assessment of orientation, naming, commands, writing, and attention, performed twice daily to detect earliest encephalopathy signs and guide ICANS grading and steroid escalation, per EBMT/EHA best‑practice recommendations 1 [Level I evidence].

Informations et précautions

Start with the 10‑point bedside neurologic screen assessing orientation, naming, command following, handwriting, and attention; a decline signals evolving ICANS and mandates urgent reassessment. Insights: highly sensitive for early cognitive changes and integrates directly into ASTCT ICANS grading 1. Cautions: may miss focal deficits, seizures, and encephalopathy with normal ICE; requires twice‑daily use; deterioration should prompt EEG/MRI/LP to exclude mimics.